Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tianshu Ren"'
Autor:
Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang, Yaoguang Huang, Weige Zhang, Shanbo Hou, Aigang Song, Yingshi Zhang, Qingchun Zhao
Publikováno v:
Pharmacological Research, Vol 203, Iss , Pp 107142- (2024)
ZLDI-8 is an A disintegrin and metalloproteinase domain 17 (ADAM17) inhibitor that suppresses the shedding of Notch1 to the Notch1 intracellular domain (NICD). In previous studies, we found that ZLDI-8 was able to sensitize HCC to sorafenib, but the
Externí odkaz:
https://doaj.org/article/512c8a7067fe44c99115207486fe10cb
Autor:
Tianshu Ren, Hui Jia, Qiong Wu, Yan Zhang, Qun Ma, Dong Yao, Xudong Gao, Danni Xie, Zihua Xu, Qingchun Zhao, Yingshi Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Bevacizumab (Bev) is a humanized vascular endothelial growth factor monoclonal antibody that is used with chemotherapeutic drugs for the treatment of metastatic colorectal cancer (mCRC). Bev-induced hypertension (HT) is the most common adverse reacti
Externí odkaz:
https://doaj.org/article/a9be20ef6f484508970e657a911f252a
Autor:
Xingshun Qi, Zhaohui Bai, Qiang Zhu, Gang Cheng, Yu Chen, Xiaowei Dang, Huiguo Ding, Juqiang Han, Lei Han, Yingli He, Fanpu Ji, Hongxu Jin, Bimin Li, Hongyu Li, Yiling Li, Zhiwei Li, Bang Liu, Fuquan Liu, Lei Liu, Su Lin, Dapeng Ma, Fanping Meng, Ruizhao Qi, Tianshu Ren, Lichun Shao, Shanhong Tang, Yufu Tang, Yue Teng, Chunhui Wang, Ran Wang, Yunhai Wu, Xiangbo Xu, Ling Yang, Jinqiu Yuan, Shanshan Yuan, Yida Yang, Qingchun Zhao, Wei Zhang, Yongping Yang, Xiaozhong Guo, Weifen Xie
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Liver cirrhosis is a major global health burden worldwide due to its high risk of morbidity and mortality. Role of terlipressin for the management of liver cirrhosis–related complications has been recognized during recent years. This ar
Externí odkaz:
https://doaj.org/article/75e3e7b045404306aa04cc89dafcad2c
Autor:
Yaoguang Huang, Deping Li, Chang Xu, Chengze Zhu, Limeng Wu, Meiling Shen, Yue Li, Xiaowen Jiang, Wenwu Liu, Qingchun Zhao, Tianshu Ren
Publikováno v:
New Journal of Chemistry. 46:20972-20984
After optimization of the lead compound, ZLHT-7, a compound with 10-fold higher selectivity for CDK2 over CDK9, was discovered.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc4404afc6504c4c6d237c421f1861f0
https://doi.org/10.1039/d2nj03591j
https://doi.org/10.1039/d2nj03591j
Publikováno v:
Breast Care.
Objectives：To evaluate the effects of gonadotropin-releasing hormone agonists (GnRHa) on pregnancy outcomes, ovarian function failure (POF), menstrual recovery, disease-free survival (DFS), and adverse events in premenopausal breast cancer patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca42ce4b78e227bb142d1cadfd8ca3e2
https://doi.org/10.1159/000528028
https://doi.org/10.1159/000528028
Publikováno v:
Clinical and experimental medicine.
Erythropoiesis-stimulating agents (ESAs) have been reported to increase the risk of death in cancer patients. In this study, we selected breast cancer, which is currently the most prevalent cancer worldwide, for a meta-analysis to re-examine the adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7acba9bc63d006c348bf0345e6a80f6a
https://pubmed.ncbi.nlm.nih.gov/36315312
https://pubmed.ncbi.nlm.nih.gov/36315312
Publikováno v:
2022 7th International Conference on Cloud Computing and Big Data Analytics (ICCCBDA).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae5546c1a6b33467781c0e4f4fb5cef1
https://doi.org/10.1109/icccbda55098.2022.9778860
https://doi.org/10.1109/icccbda55098.2022.9778860
Autor:
Qingchun Zhao, Chang Xu, Yingshi Zhang, Tianshu Ren, Zexu Shen, Shu Wang, Fuhai Hui, Xingshun Qi
Publikováno v:
Drug Safety. 44:29-40
Guidelines recommend combined doublet backbone chemotherapy based on 5-fluorouracil and oxaliplatin (OX) or irinotecan (IR) as the first-line treatment options for metastatic colorectal cancer. However, it is still unknown which is better when combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11d723152bfe490f490e589947286942
https://doi.org/10.1007/s40264-020-00997-2
https://doi.org/10.1007/s40264-020-00997-2
Autor:
Huai-Wei Ding, Tianshu Ren, Qingchun Zhao, Hong-yuan Lu, Qiong Wu, Shu Wang, Xiaochun Qin, Yingshi Zhang, Yuyan Liu
Publikováno v:
Cell Death and Disease, Vol 11, Iss 6, Pp 1-11 (2020)
Cell Death & Disease
Cell Death & Disease
Breast cancer is one of the most frequent cancers among women worldwide. However, there is still no effective therapeutic strategy for advanced breast cancer that has metastasized. Aberrant activation of the PI3K/AKT/mTOR pathway is an essential step
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374461ceef5f6c3e3dc962b4657f0056
http://link.springer.com/article/10.1038/s41419-020-2690-y
http://link.springer.com/article/10.1038/s41419-020-2690-y
Autor:
Danni Xie, Yingshi Zhang, Xudong Gao, Dong Yao, Tianshu Ren, Zihua Xu, Qun Ma, Chun Qing Zhao, Yan Zhang, Hui Jia, Qiong Wu
Bevacizumab (Bev) is a humanized vascular endothelial growth factor monoclonal antibody that is used with chemotherapeutic drugs for the treatment of metastatic colorectal cancer (mCRC). Bev-induced hypertension (HT) is the most common adverse reacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::817bd46dde66beaa91a6c3ffc2c1565a
https://doi.org/10.21203/rs.3.rs-830539/v1
https://doi.org/10.21203/rs.3.rs-830539/v1
